Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,411 | 536 | 99.6% |
| Education | $34.44 | 5 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,185 | 81 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,051 | 59 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $994.72 | 51 | $0 (2024) |
| GlaxoSmithKline, LLC. | $600.42 | 35 | $0 (2024) |
| Merck Sharp & Dohme LLC | $596.46 | 48 | $0 (2024) |
| Amgen Inc. | $513.68 | 21 | $0 (2024) |
| Novo Nordisk Inc | $493.28 | 23 | $0 (2023) |
| Lilly USA, LLC | $446.55 | 23 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $412.78 | 22 | $0 (2024) |
| PFIZER INC. | $381.46 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $778.01 | 42 | Boehringer Ingelheim Pharmaceuticals, Inc. ($205.34) |
| 2023 | $834.89 | 47 | AbbVie Inc. ($256.71) |
| 2022 | $1,307 | 67 | ABBVIE INC. ($207.31) |
| 2021 | $1,512 | 82 | AstraZeneca Pharmaceuticals LP ($304.62) |
| 2020 | $1,131 | 58 | Novo Nordisk Inc ($163.30) |
| 2019 | $1,366 | 85 | Amarin Pharma Inc. ($184.27) |
| 2018 | $1,028 | 67 | Merck Sharp & Dohme Corporation ($165.88) |
| 2017 | $1,488 | 93 | AstraZeneca Pharmaceuticals LP ($209.93) |
All Payment Transactions
541 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: DIABETES | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: RESPIRATORY | ||||||
| 11/22/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: DERMATOLOGY | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: DIABETES | ||||||
| 10/29/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Endocrinology | ||||||
| 10/17/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: DIABETES | ||||||
| 09/24/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Endocrinology | ||||||
| 09/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: Cardiology | ||||||
| 08/28/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: NEUROSCIENCE | ||||||
| 07/08/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: NEUROSCIENCE | ||||||
| 07/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: DIABETES | ||||||
| 06/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: Inflammation | ||||||
| 06/07/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: DIABETES | ||||||
| 05/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.33 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Diabetes Care | ||||||
| 05/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/07/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: DIABETES | ||||||
| 05/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Respiratory | ||||||
| 04/30/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: VACCINE | ||||||
| 04/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,987 | 4,282 | $414,710 | $229,878 |
| 2022 | 14 | 1,912 | 3,581 | $316,455 | $186,529 |
| 2021 | 11 | 978 | 2,176 | $183,220 | $109,529 |
| 2020 | 13 | 1,134 | 2,245 | $172,865 | $97,369 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 273 | 926 | $185,200 | $95,008 | 51.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 126 | 1,117 | $118,890 | $61,041 | 51.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 194 | 194 | $38,800 | $29,407 | 75.8% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 213 | 213 | $8,520 | $6,524 | 76.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 67 | 73 | $10,950 | $5,554 | 50.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 242 | 597 | $5,970 | $4,974 | 83.3% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 216 | 216 | $6,480 | $4,739 | 73.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 197 | 197 | $7,295 | $4,322 | 59.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 54 | $6,480 | $4,045 | 62.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 12 | $4,800 | $2,956 | 61.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 35 | 35 | $3,325 | $2,653 | 79.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $2,600 | $2,528 | 97.2% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 11 | 11 | $3,300 | $2,113 | 64.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 214 | 401 | $4,010 | $1,367 | 34.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 37 | 37 | $2,405 | $1,331 | 55.4% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 64 | 141 | $1,410 | $716.28 | 50.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 45 | 45 | $4,275 | $600.28 | 14.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 258 | 940 | $188,000 | $99,104 | 52.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 207 | 207 | $41,400 | $32,416 | 78.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 105 | 424 | $38,160 | $25,579 | 67.0% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2022 | 211 | 211 | $8,440 | $6,750 | 80.0% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 214 | 214 | $6,420 | $4,874 | 75.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 160 | 160 | $4,000 | $3,575 | 89.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 52 | 52 | $3,380 | $3,312 | 98.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 45 | $5,400 | $3,112 | 57.6% |
About Dr. Francine Dimaria, D.O
Dr. Francine Dimaria, D.O is a Family Medicine healthcare provider based in Deer Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144297045.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Francine Dimaria, D.O has received a total of $9,445 in payments from pharmaceutical and medical device companies, with $778.01 received in 2024. These payments were reported across 541 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($9,411).
As a Medicare-enrolled provider, Dimaria has provided services to 6,011 Medicare beneficiaries, totaling 12,284 services with total Medicare billing of $623,305. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Deer Park, NY
- Active Since 03/01/2006
- Last Updated 03/06/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1144297045
Products in Payments
- JARDIANCE (Drug) $1,219
- VRAYLAR (Drug) $445.29
- TRELEGY ELLIPTA (Drug) $394.71
- Otezla (Drug) $377.77
- Vascepa (Drug) $362.28
- UBRELVY (Drug) $360.14
- JANUVIA (Drug) $333.79
- Edarbi (Drug) $331.47
- Livalo (Drug) $325.72
- XARELTO (Drug) $283.46
- FARXIGA (Drug) $275.51
- NURTEC ODT (Drug) $258.13
- SYMBICORT (Drug) $243.22
- Ozempic (Drug) $242.53
- SYNTHROID (Drug) $203.49
- BREZTRI (Drug) $187.53
- Trintellix (Drug) $176.47
- Synthroid (Drug) $144.61
- INVOKANA (Drug) $129.32
- Prolia (Biological) $121.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Deer Park
Behrouz Farahmandpour, D.o, D.O
Family Medicine — Payments: $30,635
Dr. Edwardo Yambo, Md, MD
Family Medicine — Payments: $7,067
Dr. Basil Griffin, M.d, M.D
Family Medicine — Payments: $5,527
Joseph Dic, D.o, D.O
Family Medicine — Payments: $4,468
Dr. Marc Lewandoski, Do, DO
Family Medicine — Payments: $4,031
Dr. Julie Moran, M.d, M.D
Family Medicine — Payments: $3,539